Stone X Group Inc. Genmab A/S Transaction History
Stone X Group Inc.
- $1.55 Billion
- Q4 2024
A detailed history of Stone X Group Inc. transactions in Genmab A/S stock. As of the latest transaction made, Stone X Group Inc. holds 66,103 shares of GMAB stock, worth $1.44 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
66,103Holding current value
$1.44 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
244Shares Held
61.2MCall Options Held
159KPut Options Held
38K-
Alliancebernstein L.P. New York, NY14.9MShares$325 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$111 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$67.3 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$61.3 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$61.1 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.3B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...